ORTOMA AB B (82Y) - Total Liabilities
Based on the latest financial reports, ORTOMA AB B (82Y) has total liabilities worth €18.63 Million EUR (≈ $21.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ORTOMA AB B - Total Liabilities Trend (2021–2025)
This chart illustrates how ORTOMA AB B's total liabilities have evolved over time, based on quarterly financial data. See 82Y working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
ORTOMA AB B Competitors by Total Liabilities
The table below lists competitors of ORTOMA AB B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dcon Products Public Company Limited
BK:DCON
|
Thailand | ฿1.10 Billion |
|
TDb Split Corp
TO:XTD
|
Canada | CA$47.56 Million |
|
Beamtree Holdings Ltd
AU:BMT
|
Australia | AU$13.76 Million |
|
Aquirian Ltd
AU:AQN
|
Australia | AU$21.75 Million |
|
NIGHTINGALE HEALTH EO 1
F:7XE
|
Germany | €9.06 Million |
|
Citigold Corporation Ltd
AU:CTO
|
Australia | AU$21.77 Million |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
Korea | ₩2.60 Trillion |
|
Alpha Trust Andromeda Investment Trust S.A
AT:ANDRO
|
Greece | €2.26 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ORTOMA AB B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ORTOMA AB B (82Y) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ORTOMA AB B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ORTOMA AB B (2021–2025)
The table below shows the annual total liabilities of ORTOMA AB B from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €18.63 Million ≈ $21.78 Million |
-2.35% |
| 2024-12-31 | €19.07 Million ≈ $22.30 Million |
+1.48% |
| 2023-12-31 | €18.80 Million ≈ $21.97 Million |
-49.23% |
| 2022-12-31 | €37.02 Million ≈ $43.28 Million |
+836.96% |
| 2021-12-31 | €3.95 Million ≈ $4.62 Million |
-- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more